Democrat Presidential Candidates pledge to lower drug prices without Congress’ help

pharmafile | January 15, 2020 | News story | Research and Development Bernie Sanders, GOP, Trump, US President, US Presidential Election, democrats, republican 

Two Democratic presidential candidates said that if they are elected president they will act immediately to reduce the cost of certain drugs, with or without the help of Congress.

Both Senator Elizabeth Warren of Massachusetts and Senator Amy Klobuchar of Minnesota, said they would act independently of Congress and said that the powers of the presidency means they have the legal authority to rein in prices without Congressional action.

The comments came during Tuesday’s Democratic debate, but both did not outline what specific presidential power they would use.

Klobuchar says she has a list of 137 things she could do without Congressional approval. She later added that the many pharmaceutical lobby groups donating to Congressional campaigns means meaningful legislation on drug prices can’t get past.

Warren says she would act to lower the cost of insulin and drugs that treat HIV/AIDS, as well as the price of EpiPen, Humira and Naloxone.

The price of prescription drugs has been an ongoing debate across the aisle in American politics. In December, the Trump administration took steps to allow the importation of certain prescription drugs from Canada. Democrats clearly feel more action is needed to address the fact that 29% of Americans cannot take prescription drugs as directed, as they cannot afford them.

Conor Kavanagh

Related Content

Profits over patients: US pharma spending billions on investor payouts

In 2017 Donald Trump signed the Tax Cuts and Jobs Act (TCJA), creating billions of …


US pharma lobby launches legal action against the Trump administration over drug pricing proposals

US industry organisations including the Pharmaceutical Research and Manufacturers of America (PhRMA) have launched legal …


How the US election could affect the pharmaceutical industry

The US is one of the most lucrative markets for the pharmaceutical industry. This is a …

Latest content